期刊
EUROPEAN HEART JOURNAL
卷 37, 期 23, 页码 1850-1858出版社
OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/ehv727
关键词
Dilated cardiomyopathy; Position statement; Heart failure
资金
- Roche Diagnostics
- Novartis
- MyoKardia
- Shire HGT
- Genzyme a sanofi comp.
- Amicus Therpautics
- Actelion Pharmaceuticals
- Boehringer Ingelheim
- Genzyme
- Shire
- Pfizer
- Amicus
In this paper the Working Group on Myocardial and Pericardial Disease proposes a revised definition of dilated cardiomyopathy (DCM) in an attempt to bridge the gap between our recent understanding of the disease spectrum and its clinical presentation in relatives, which is key for early diagnosis and the institution of potential preventative measures. We also provide practical hints to identify subsets of the DCM syndrome where aetiology directed management has great clinical relevance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据